VaxGen Common Stock Expected to Qualify for Quotation on OTC Bull...(action will be included in the proxystat...)

Date:12/20/2007

action will be included in the proxy statement/prospectus described above. Additional information regarding the directors and executive officers of VaxGen is also included in VaxGen's definitive proxy statement for its 2007 Annual Meeting of Stockholders which was filed with the SEC on November 21, 2007 and its Annual Report on Form 10-K for the year ended December 31, 2006, which was filed with the SEC on August 30, 2007. These documents are available free of charge at the SEC's web site at http://www.sec.gov and from Investor Relations at VaxGen as described above.

'/>"/>

SOURCE VaxGen Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. VaxGen Files 2006 Financial Statements and Provides Cash Update
2. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
3. VaxGen Files First Quarter 2007 Financials
4. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
5. VaxGen Files Last Outstanding Periodic Report With SEC
6. VaxGen Addresses MPM Claims in Letter to Stockholders
7. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
8. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
9. Viragen International to Reverse Split Its Common Stock
10. Exelixis Announces Closing of Public Offering of Common Stock
11. BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends